Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2
Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and inflammatory diseases. Its key research area involves nuclear receptors as target proteins for the development of new pharmaceuticals. Karo Pharma discovers drugs to target major diseases such as dyslipidemia; diabetes; autoimmune diseases such as rheumatoid arthritis, ulcerative colitis and multiple sclerosis; inflammation, multiple types of cancer, viral and bacterial infections. The company s projects are based on ROR gamma receptor and estrogen receptor. Its development pipeline also includes T268A Cold Spray which utilizes glucose oxidase enzyme in combination with glucose to fight against cold virus. Karo Pharma is headquartered in Huddinge, Stockholm, Sweden. Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary in-house Power etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of 3
the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH59487D Number of Pages : 34 Report Format : PDF Publisher Information : 4
5
Table Of Contents for Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5Karo Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8Karo Pharma AB, Medical Devices Deals, 2010 to YTD 2016 10Karo Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11Karo Pharma AB, Pharmaceuticals & Healthcare, Deal Details 12Partnerships 12Karo Bio Enters Into Research Agreement With 4D Science 12Karo Bio Extends Research Agreement With Pfizer For RORgamma Modulators 13Karo Bio Enters Into Research Agreement With Pfizer For RORgamma Modulators 14Karo Bio Extends Research Agreement With Zydus Cadila 16Karo Bio Terminates Its Collaboration With Merck & Co For MK-6913 17Licensing Agreements 18Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 18Karo Bio Enters Into Licensing Agreement With Alkem 19Equity Offering 21Karo Bio to Raise USD29.7 Million in Rights Offering of Preferred Shares 21Karo Bio Raises USD29 Million in Rights Offering of Shares 23Karo Bio Raises USD12 Million in Rights Offering of Shares 25Karo Bio Raises USD1 Million in Private Placement of Shares 26Karo Bio Completes Rights Offering of Shares for USD4.9 Million 27Karo Bio Completes Rights Offering Of US$49 Million 28Acquisition 30Karo Bio Acquires Tanomed for USD2.3 Million 30Karo Pharma AB - Key Competitors 31Key Employees 32Locations And Subsidiaries 33Head Office 33Other Locations & Subsidiaries 33Appendix 34Methodology 34About GlobalData 34Contact Us 34Disclaimer 34 6
List Of Tables in Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Karo Pharma AB, Pharmaceuticals & Healthcare, Key Facts, 2015 1 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Karo Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Karo Pharma AB, Deals By Therapy Area, 2010 to YTD 2016 8 Karo Pharma AB, Medical Devices Deals, 2010 to YTD 2016 10 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11 Karo Bio Enters Into Research Agreement With 4D Science 12 Karo Bio Extends Research Agreement With Pfizer For RORgamma Modulators 13 Karo Bio Enters Into Research Agreement With Pfizer For RORgamma Modulators 14 Karo Bio Extends Research Agreement With Zydus Cadila 16 Karo Bio Terminates Its Collaboration With Merck & Co For MK-6913 17 Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 18 Karo Bio Enters Into Licensing Agreement With Alkem 19 Karo Bio to Raise USD29.7 Million in Rights Offering of Preferred Shares 21 Karo Bio Raises USD29 Million in Rights Offering of Shares 23 Karo Bio Raises USD12 Million in Rights Offering of Shares 25 Karo Bio Raises USD1 Million in Private Placement of Shares 26 Karo Bio Completes Rights Offering of Shares for USD4.9 Million 27 Karo Bio Completes Rights Offering Of US$49 Million 28 Karo Bio Acquires Tanomed for USD2.3 Million 30 Karo Pharma AB, Key Competitors 31 Karo Pharma AB, Key Employees 32 Karo Pharma AB, Subsidiaries 33 7
List Of Figures, Charts and Diagrams in Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8 Karo Pharma AB, Medical Devices Deals, 2010 to YTD 2016 10 8
How to Buy... Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 9